论文部分内容阅读
背景:表阿霉素(epirubicin)、顺铂、氟尿嘧啶静脉持续滴注(ECF)疗法可以改善不能治愈的患有局部晚期或者转移性胃腺癌患者的生存率。我们对手术期间增加ECF疗法是否可以改善有治愈可能胃癌患者的治疗结果。方法:我们将患有胃部、食管胃交界处或者食管下段癌症的患者随机进行手?
BACKGROUND: Epirubicin, cisplatin and fluorouracil continuous intravenous infusion (ECF) therapy can improve the survival rate of patients with locally advanced or metastatic gastric adenocarcinoma who can not be cured. Our question as to whether increasing ECF therapy during surgery can improve treatment outcomes in patients with potentially cancerous gastric cancer. Methods: We randomized patients with stomach, esophagogastric junction or lower esophageal cancer.